Skip to main content

A hail and farewell for Bess Levin

Image result for Bess Levin

Bess Levin, for more than ten years the guiding genius behind the Wall Street gossip blog and humor rag Dealbreaker, is leaving that post.  This is a good time for a moment of silence.

On Friday, October 28, Bess broke the news to the world under the headline, “Housekeeping: This Is One of My Last Posts for Dealbreaker.” She’s moving to Vanity Fair’s The Hive.

Props to VF, but it won’t be the same.

Dealbreaker during Levin’s tenure has with some regularity turned its sharp and often sex-obsessed lens on the world of alpha seekers.  Recent efforts include the Thornton McEnery post about Pete Muller, manager of a $5 billion quant fund firm, and musician on the side, who has composed a little ditty about Ken Griffin’s post-divorce sex life.

Highland Hijinks       

Bess’ own recent writing includes an item this September about Joshua Terry’s lawsuit against Highland Capital. The story consisted of three equal parts. From bottom to top these were: a quote from a boring Bloomberg story on that lawsuit; a paragraph in which Bess re-aligned the issues at stake invoking such burning irrelevancies as Joshua Terry’s stature; and a long headline that says it all best.  I’ll quote only the headline here:  “Hedge fund employee who claims he was fired for getting in way of boss’ plans to use investor funds on South American condom factory will get his day in court.”

Now that’s a headline that gets you thinking. And perhaps even researching. There is of course no reason a priori why a hedge fund manager might not want to invest in a South American condom factory. Perhaps this qualifies as going long on the decline of traditional Roman Catholic mores on the matter of contraception. Or something.  

The legal point is Terry’s claim, filed initially in a state court in Dallas County, Texas, now set for arbitration, that certain outside investors were due repayment of loans, and that Highland’s president, James Dondero, had misdirected those funds to the condom factory: that is, that the condom deal was illegal self-dealing. Does this make Terry a whistle blower? Does it mean that the ostensible reasons he was fired are pretextual?

Bess wasn’t breaking any stories there (that wasn’t and isn’t part of Dealbreaker’s business model), she was riffing on a Bloomberg story. But doing it well. 

Remember Bear Stearns’ High-Grade Structured Credit Fund? 

But enough of the recent stuff. Let’s go for a deeper dive. Dealbreaker in general and Bess in particular seem to have divined earlier than most than the fall of Ralph Cioffi and Matt Tannin was going to be big. DB followed with great though bemused care the collapse in 2007 of the Bear Stearns hedge funds that C&T headed, the strained relations between those two managers and the rest of the ursine family thereafter, and the eventual trial of C&T (which, lest we forget, ended with acquittal for both).  In December 2007, Bess invoked Michael Corleone in this connection: “Ralph Cioffi: Just When He Was Out, They Drag Him Back In.” Her point in that post was that Cioffi, fresh off the failure of his two Bear- branded funds, was trying to put together another. What was the obstacle? That Bear Stearns was “using his millions of restricted stock to try to persuade him to stay on.” 

The failures themselves? Apparently not an obstacle at all. As Bess observed, “hedge fund failure might not quite mean never having to say you’re sorry but it certainly doesn’t mean you’ll never eat lunch at San Pietro again.”  

After the Cuff Shots

Obviously, alluding to a classic quote from only one movie was not sufficient to the occasion. 

Cioffi and Tannin were arrested the following summer.  During their trial, Bess found some humor in imagining their relationship to their one-time boss, Bear Stearns CEO James Cayne, who is also fondly remembered as a bridge player and a recreational marijuana smoker. 

As Bess put it while Cioffi was awaiting trial, “the offer to smoke a J [was] probably just the thing that could lift Cioffi’s spirits” yet – alas! There was “nary a peep from his stoner boss. Of course, there’s a logical explanation for the silence – Cayne [was] too busy running down the list of opponents ‘’ and telling reporters they’re all gay….”  Amazing, funny stuff. And Cayne was lucky enough to come back within Bess’ scope earlier this year. 

I don't really miss Cayne at all. But I'm gonna miss Bess.


  1. VaporFi is the highest quality electronic cigarettes provider out there.


Post a Comment

Popular posts from this blog

England as a Raft?

In a lecture delivered in 1880, William James asked rhetorically, "Would England ... be the drifting raft she is now in European affairs if a Frederic the Great had inherited her throne instead of a Victoria, and if Messrs Bentham, Mill, Cobden, and Bright had all been born in Prussia?"

Beneath that, in a collection of such lectures later published under James' direction, was placed the footnote, "The reader will remember when this was written."

The suggestion of the bit about Bentham, Mill, etc. is that the utilitarians as a school helped render England ineffective as a European power, a drifting raft.

The footnote was added in 1897. So either James is suggesting that the baleful influence of Bentham, Mill etc wore off in the meantime or that he had over-estimated it.

Let's unpack this a bit.  What was happening in the period before 1880 that made England seem a drifting raft in European affairs, to a friendly though foreign observer (to the older brother…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Francesco Orsi

I thought briefly that I had found a contemporary philosopher whose views on ethics and meta-ethics checked all four key boxes. An ally all down the line.

The four, as regular readers of this blog may remember, are: cognitivism, intuitionism, consequentialism, pluralism. These represent the views that, respectively: some ethical judgments constitute knowledge; one important source for this knowledge consists of quasi-sensory non-inferential primary recognitions ("intuitions"); the right is logically dependent upon the good; and there exists an irreducible plurality of good.

Francesco Orsi seemed to believe all of these propositions. Here's his website and a link to one relevant paper:

What was better: Orsi is a young man. Born in 1980. A damned child! Has no memories of the age of disco!

So I emailed him asking if I was right that he believed all of those things. His answer: three out of …